Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic Sepsis

New England Journal of Medicine

Volumn 317, Issue 11, 1987, Pages 659-665

 

^a West Haven Veteran's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE;

CONTROLLED STUDY; EPIDEMIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; SEPSIS; THERAPY;

CLINICAL TRIALS; DOUBLE-BLIND METHOD; HUMANS; METHYLPREDNISOLONE; MIDDLE AGED; RANDOM ALLOCATION; SEPSIS;

EID: 0023239471     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198709103171102     Document Type: Article

References (29)

1. McCabe WR. Gram-negative bacteremia. Adv Intern Med 1974; 19: 135–58.
2. Kreger BE, Craven DE, McCabc WR. Gram-negative bacteremia. IV. Reevaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344–55.
3. Kass EH, Ingbar SH, Finland M. Effects of adrenocorticotropic hormone in pneumonia: clinical, bacteriological and serological studies. Ann Intern Med 1950; 33: 1081–98.
4. Weissmann G, Thomas L. Studies on lysosomes. I. The effects of endotoxin, endotoxin tolerance, and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver. J Exp Med 1962; 116: 433–50.
5. Lillehei RC, Longerbeam JK, Bloch JH. Physiology and therapy of bacteremic shock: experimental and clinical observations. Am J Cardiol 1963; 12: 599–613.
6. Hinshaw LB, Archer LT, Beller-Todd BK, et al. Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res 1980; 28: 151–70.
7. Hinshaw LB, Archer LT, Beller-Todd BK, Benjamin B, Flournoy DJ, Passey R. Survival of primates in lethal septic shock following delayed treatment with steroid. Circ Shock 1981; 8: 291–300.
8. Hinshaw LB, Beller-Todd BK, Archer LT, et al. Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Ann Surg 1981; 194: 51–6.
9. Hinshaw LB, Beller-Todd BK, Archer LT. Current management of the septic shock patient: experimental basis for treatment. Circ Shock 1982; 9: 543–53.
10. Greisman SE, DuBuy JB, Woodward CL. Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone. Infect Immun 1979; 25: 538–57.
11. Greisman SE. Experimental gram-negative bacterial sepsis: optimal methylprednisolone requirements for prevention of mortality not preventable by antibiotics alone. Proc Soc Exp Biol Med 1982; 170: 436–42.
12. Pitcairn M, Schuler J, Erve PR, Holtzman S, Schumer W. Glucocorticoid and antibiotic effect on experimental gram-negative bacteremic shock. Arch Surg 1975; 110: 1012–5.
13. Balis JU, Paterson JF, Shelley SA, Larson CH, Fareed J, Gerber LI. Glucocorticoid and antibiotic effects on hepatic microcirculation and associated host responses in lethal gram-negative bacteremia. Lab Invest 1979; 40: 55–65.
14. Fabian TC, Patterson R. Steroid therapy in septic shock: survival studies in a laboratory model. Ann Surg 1982; 48: 614–7.
15. Schaefer CF, Brackett DJ, Wilson MF. The benefits of corticosteroid given after the onset of hypotension during endotoxin shock in the conscious rat. Adv Shock Res 1983; 10: 183–94.
16. Schuler JJ, Erve PR, Schumer W. Glucocorticoid effect on hepatic carbohydrate metabolism in the endotoxin-shocked monkey. Ann Surg 1976; 183: 345–54.
17. White GL, Archer LT, Beller BK, Hinshaw LB. Increased survival with methylprednisolone treatment in canine endotoxin shock. J Surg Res 1978; 25: 357–64.
18. Hinshaw LB, Beller BK, Archer LT, Flournoy DJ, White GL, Phillips RW. Recovery from lethal Escherichia coli shock in dogs. Surg Gynecol Obstet 1979; 149: 545–53.
19. Beller BK, Archer LT, Passey RB, Flournoy DJ, Hinshaw LB. Effectiveness of modified steroid-antibiotic therapies for lethal sepsis in the dog. Arch Surg 1983; 118: 1293–9.
20. Reichgott MJ, Melmon KL. Should corticosteroids be used in shock? Med Clin North Am 1973; 57: 1211–23.
21. Weitzman S, Berger S. Clinical trial design in studies of corticosteroids for bacterial infections. Ann Intern Med 1974; 81: 36–42.
22. Sheagren JN. Septic shock and corticosteroids. N Engl J Med 1981; 305: 456–8.
23. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976; 184: 333–41.
24. Sheagren JN. Glucocorticoid therapy in the management of severe sepsis. In: Root RK, Sande MA, eds. Septic shock. New York: Churchill Living-stone, 1985:201–18.
25. Shine KI, Kuhn M, Young LS, Tillisch JM. Aspects of the management of shock. Ann Intern Med 1980; 93: 723–34.
26. Weil MH, Henning RJ. New concepts in the diagnosis and fluid treatment of circulatory shock: thirteenth annual Becton, Dickinson and Company Oscar Schwidetsky Memorial Lecture. Anesth Analg 1979; 58: 124–32.
27. Armitage P. Sequential medical trials. 2nd ed. New York: John Wiley, 1975:52–63.
28. Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 1984; 311: 1137–43.
29. Hoffman SL, Punjabi NH, Kumala S, et al. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 1984; 310: 82–8.